Jeffrey G. Black - 15 May 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
SVP & Chief Financial Officer
Signature
/s/Jeffrey G Black by Agnieszka Gallagher, Attorney-in-Fact
Issuer symbol
LAB
Transactions as of
15 May 2023
Net transactions value
$0
Form type
4
Filing time
17 May 2023, 21:10:29 UTC
Previous filing
04 Apr 2023
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LAB Restricted Stock Units Award $0 +210,526 $0.000000 210,526 15 May 2023 Common Stock 210,526 Direct F1, F2
transaction LAB Stock Option (Right to Buy) Award $0 +400,000 $0.000000 400,000 15 May 2023 Common Stock 400,000 $1.90 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2 Restricted Stock Units vest as to 1/4 of the underlying shares on May 15, 2024, and as to an additional 1/16th of the total number of shares every three months thereafter, subject to Mr. Black's continued service through the applicable vesting date.
F3 The Option becomes exercisable as to 1/4th of the underlying shares on May 15, 2024, and as to an additional 1/48th of the total number of shares each month thereafter, subject to Mr. Black's continued service through the applicable vesting date.